| hypromellose 2208 (15000 mpa.s) | INACTIVE INGREDIENT | Z78RG6M2N2 | Natural Vaginal Care | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | METFORMIN HYDROCHLORIDE, USP TABLETS and METFORMIN HYDROCHLORIDE, USP EXTENDED-RELEASE TABLETS | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use INTUNIV safely and effectively. See full prescribing information for INTUNIV . INTUNIV (guanfacine) extended-release tablets, for oral use Initial U.S. Approval: 1986 ® ® ® | 4 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use PREMPRO/PREMPHASE safely and effectively. See full prescribing information for PREMPRO/PREMPHASE. PREMPRO ® (conjugated estrogens/medroxyprogesterone acetate tablets) PREMPHASE ® (conjugated estrogens plus medroxyprogesterone acetate tablets) Initial U.S. Approval: 1995 | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use Lescol ® / Lescol ® XL safely and effectively. See full prescribing information for Lescol ® / Lescol ® XL. Lescol ® (fluvastatin sodium) capsules/ Lescol ® XL (fluvastatin sodium) extended-release tablets for oral use Initial U.S. Approval: 1993/ 2000 | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use PRISTIQ safely and effectively. See full prescribing information for PRISTIQ. PRISTIQ ® (desvenlafaxine) Extended-Release Tablets, oral Initial U.S. Approval: 2008 | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMARIN ® (conjugated estrogens tablets, USP) | 1 | |
| Hypromellose 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use XELODA ® safely and effectively. See full prescribing information for XELODA ® . XELODA ® (capecitabine) Tablets, Film Coated for Oral use Initial U.S. Approval: 1998 | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MORPHINE SULFATE ER - C-II TABLETS - 15MG, 30MG | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 2000 | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | DRUG FACTS | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | DRUG FACTS | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | DRUG FACTS | 1 | |
| Hypromellose 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | 8a023942-01e8-4849-aa3c-1a640ffc7fd3 | 7 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Glycare Acne Gel | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | 0d466214-78a8-44cd-923c-c286a0f74f66 | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | 709031e4-4c20-4ea7-beff-6c459709a433 | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Sprintec ® (norgestimate and ethinyl estradiol tablets) Rx only | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | Digozin | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Fact | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Fact | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MORPHINE SULFATE EXTENDED-RELEASE TABLETS 15 mg, 30 mg, 60 mg, 100 mg*, 200 mg* CII Rx only *100 and 200 mg for use in opioid tolerant patients only | 2 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Fact | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Fact | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Fact | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Fact | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | Drug Facts | 2 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMARIN ® (conjugated estrogens tablets, USP) | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | XELODA ® (capecitabine) TABLETS | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | d27ca215-001c-411b-893e-a8a6200f364e | 2 | |
| hypromellose 2208 (15000 mpa.s) | INACTIVE INGREDIENT | Z78RG6M2N2 | TRANDATE ® (labetalol hydrochloride) Tablets | 4 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | ETHAMBUTOL HYDROCHLORIDE TABLETS, USP | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | These highlights do not include all the information needed to use Tekturna HCT safely and effectively. See full prescribing information for Tekturna HCT . Tekturna HCT (aliskiren and hydrochlorothiazide) T ablets Initial U.S. Approval: 2008 | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3747 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3692 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3690 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3678 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [LAKE ERIE MEDICAL SURGICAL & SUPPLY DBA QUALITY CARE PRODUCTS LLC] | 3057 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PRISTIQ EXTENDED RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC] | 2068 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | CETIRIZINE HCL AND PSEUDOEPHEDRINE HCL ER (CETIRIZINE HCL AND PSEUDOEPHEDRINE HCL) TABLET, FILM COATED, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 1000 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | ETHAMBUTOL HYDROCHLORIDE (ETHAMBUTOL HYDROCHLORIDE) TABLET [REMEDYREPACK INC. ] | 84 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | DIGOXIN TABLET [REMEDYREPACK INC. ] | 47 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 47 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | METHYLPHENIDATE HYDROCHLORIDE TABLET METHYLPHENIDATE HYDROCHLORIDE TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.] | 29 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | INTUNIV (GUANFACINE) TABLET, EXTENDED RELEASE INTUNIV (GUANFACINE) KIT [SHIRE US MANUFACTURING INC.] | 27 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMPHASE (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) KIT PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE) TABLET, SUGAR COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 22 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMARIN (ESTROGENS, CONJUGATED) TABLET, FILM COATED [WYETH PHARMACEUTICALS INC., A SUBSIDIARY OF PFIZER INC.] | 21 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | AMITRIPTYLINE HYDROCHLORIDE TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 20 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MORPHINE SULFATE TABLET, EXTENDED RELEASE [MALLINCKRODT, INC.] | 19 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | SINGULAIR (MONTELUKAST SODIUM) TABLET, CHEWABLE SINGULAIR (MONTELUKAST SODIUM) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS LLC] | 12 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | CIPROFLOXACIN TABLET, FILM COATED [PD-RX PHARMACEUTICALS, INC.] | 11 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [PD-RX PHARMACEUTICALS, INC.] | 11 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | METFORMIN HYDROCHLORIDE TABLET, FILM COATED METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [WATSON PHARMA, INC.] | 11 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LESCOL (FLUVASTATIN SODIUM) CAPSULE LESCOL XL (FLUVASTATIN SODIUM) TABLET, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION] | 10 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PRISTIQ EXTENDED-RELEASE (DESVENLAFAXINE SUCCINATE) TABLET, EXTENDED RELEASE [CARDINAL HEALTH] | 10 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | METOPROLOL TARTRATE TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 9 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PREMARIN (CONJUGATED ESTROGENS) TABLET, FILM COATED [CARDINAL HEALTH] | 9 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [SUN PHARMA GLOBAL FZE] | 8 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MINOCYCLINE HYDROCHLORIDE TABLET, EXTENDED RELEASE [SANDOZ INC] | 8 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | CIPROFLOXACIN TABLET, FILM COATED [CARLSBAD TECHNOLOGY, INC.] | 7 | |
| hypromellose 2208 (15000 mpa.s) | INACTIVE INGREDIENT | Z78RG6M2N2 | KOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [E.R. SQUIBB & SONS, L.L.C.] | 7 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LEVETIRACETAM TABLET, FILM COATED, EXTENDED RELEASE [APOTEX CORP.] | 7 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | ETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC] | 6 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LABETALOL HYDROCHLORIDE TABLET [MAJOR PHARMACEUTICALS] | 6 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | STARLIX (NATEGLINIDE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 6 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | DIGOXIN TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 5 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | FLUVASTATIN SODIUM ER (FLUVASTATIN SODIUM) TABLET, EXTENDED RELEASE [SANDOZ INC] | 5 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | JOLESSA (LEVONORGESTREL / ETHINYL ESTRADIOL) KIT [BARR LABORATORIES INC.] | 5 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LIDOCAINE HYDROCHLORIDE JELLY [HI-TECH PHARMACAL CO., INC.] | 5 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | METFORMIN HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.] | 5 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | SITAVIG (ACYCLOVIR) TABLET, DELAYED RELEASE [CIPHER PHARMACEUTICALS US LLC] | 5 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | FAMOTIDINE TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 4 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LABETALOL HYDROCHLORIDE TABLET [CARDINAL HEALTH] | 4 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | PERIO GS (HYDROCOTYLE ASIATICA, ECHINACEA PURPUREA, AND SAMBUCUS NIGRA FLOWER) GEL [IZUN PHARMACEUTICALS CORPORATION] | 4 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | KAPVAY (CLONIDINE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 3 | |
| hypromellose 2208 (15000 mpa.s) | INACTIVE INGREDIENT | Z78RG6M2N2 | KOMBIGLYZE XR (SAXAGLIPTIN AND METFORMIN HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [ASTRAZENECA PHARMACEUTICALS LP] | 3 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | OMEPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [KAISER FOUNDATION HOSPITALS] | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | ACTIVE MOIETY | Z78RG6M2N2 | VISCO SHIELD LUBRICANT (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OASIS MEDICAL, INC.] | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | ACTIVE INGREDIENT | Z78RG6M2N2 | VISCO SHIELD LUBRICANT (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OASIS MEDICAL, INC.] | 3 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | CLONIDINE HYDROCHLORIDE EXTENDED-RELEASE (CLONIDINE HYDROCHLORIDE) TABLET, EXTENDED RELEASE [CONCORDIA PHARMACEUTICALS INC.] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | EPLERENONE (EPLERENONE ) TABLET [APOTEX CORP] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | ETODOLAC TABLET, FILM COATED, EXTENDED RELEASE [CARILION MATERIALS MANAGEMENT] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | FELODIPINE TABLET, EXTENDED RELEASE [HERITAGE PHARMACEUTICALS INC.] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | FLUVOXAMINE MALEATE TABLET, FILM COATED [BRYANT RANCH PREPACK] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | LEVETIRACETAM EXTENDED-RELEASE (LEVETIRACETAM) TABLET, EXTENDED RELEASE [GOLDEN STATE MEDICAL SUPPLY, INC.] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | MORPHINE SULFATE EXTENDED-RELEASE (MORPHINE SULFATE) TABLET [BRYANT RANCH PREPACK] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | PERPHENAZINE TABLET, FILM COATED [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS] | 2 | |
| hypromellose 2208 (15000 mpa.s) | INACTIVE INGREDIENT | Z78RG6M2N2 | QUINIDINE GLUCONATE TABLET, EXTENDED RELEASE [RICHMOND PHARMACEUTICALS, INC.] | 2 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | CEFPROZIL TABLET, FILM COATED [APOTEX CORP] | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | CIPROFLOXACIN (CIPROFLOXACIN) TABLET, FILM COATED [AVKARE, INC.] | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | ERY-TAB (ERYTHROMYCIN) TABLET [REMEDYREPACK INC. ] | 1 | |
| HYPROMELLOSE 2208 (15000 CPS) | INACTIVE INGREDIENT | Z78RG6M2N2 | ERY-TAB (ERYTHROMYCIN) TABLET, DELAYED RELEASE [KAISER FOUNDATION HOSPITALS] | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | ETHAMBUTOL HYDROCHLORIDE TABLET [REMEDYREPACK INC. ] | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | INACTIVE INGREDIENT | Z78RG6M2N2 | FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE ) TABLET [REMEDYREPACK INC. ] | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | ACTIVE MOIETY | Z78RG6M2N2 | IMPROVUE (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OCULUS SURGICAL, INC.] | 1 | |
| HYPROMELLOSE 2208 (15000 MPA.S) | ACTIVE INGREDIENT | Z78RG6M2N2 | IMPROVUE (HYPROMELLOSE 2208 (15000 MPA.S)) SOLUTION/ DROPS [OCULUS SURGICAL, INC.] | 1 | |